Clinical Trial Update: To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cadonilimab with SOX as neoadjuvant therapy for resectable locally advanced gastric or gastroesophageal junction adenocarcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Sichuan University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN